Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
Sign in with Google. Opens in new tab
bullish
Dr. Reddy's Laboratories
Watchlist
Dr Reddys Labs: Stable Results Despite Industry Headwinds; Maintain BUY
Equity Bottom-Up
437 Views
20 May 2022 08:04
Broker
The company is building a global pipeline of biosimilars, developments of NCE for Immuno-oncology, and building up a Neutraceuticals portfolio,...
SUMMARY
(Sign Up to Access)
Full Insight
(Paid Plans Only, 12-minute read)
Related Insights
More »
Loading
Trending Collections
More »
Index Rebalance
Japan
Equity Bottom-Up
Sell / Short Ideas
India
Event-Driven
Philippines
South Korea
Unpaywalled Insights
China
Trending Insights
More »
LQ45 Index Rebalance Preview (Jul 2025): Identifying Potential Index Changes
SM Investments Placement: Large Deal to Digest
[Japan M&A] Polaris MBO for DD Group (3073) - Too Light But Probably a Done Deal
HK-Listed Apparel & Footwear Screener July 2025: August 1st Deadline Approaches
StubWorld: Absent Borrow, GMO Internet (4784) Is An Avoid
Top Unpaywalled Insights
More »
Veon's (Nasdaq: VEON) Subsidiary Kyivstar Eyes Nasdaq Listing
Reimagining Venture Capital Through Impact Investing | Chris Maher on Disability Innovation
[IO Technicals 2025/28] Bullish Momentum Intensifies
Mid-Year Themes Review - Part II
De-Dollarisation Debate : Unmasking USD Over-Valuation
Discussions
(Paid Plans Only)
Price Chart
(Sign Up to Access)
Insight Stream
Dr Reddys Labs: Stable Results Despite Industry Headwinds; Maintain BUY
20 May 2022
Top
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.53.10
x